U.S. Luxury Stock News

NYSEAM:FLYX
NYSEAM:FLYXAirlines

Assessing flyExclusive’s Valuation After New Starlink Deal And North Carolina Expansion

Why flyExclusive’s Starlink deal is catching investor attention flyExclusive (FLYX) has drawn fresh attention after signing an authorized dealership agreement with Starlink, pairing that connectivity deal with the ongoing expansion of its maintenance offerings and broader growth initiatives in North Carolina. See our latest analysis for flyExclusive. The recent Starlink dealership, new Raleigh office and follow-on equity filing come alongside a sharp rebound in sentiment, with a 30 day share...
NasdaqGS:AMPH
NasdaqGS:AMPHPharmaceuticals

Is Amphastar Pharmaceuticals (AMPH) Attractively Priced After Recent Share Price Weakness?

If you are wondering whether Amphastar Pharmaceuticals' current share price reflects its true worth, you are not alone. This article is designed to help you assess that. The stock last closed at US$27.74, with returns of 3.6% over the past week, 8.1% over the past month, 4.8% year to date and a 24.3% decline over the past year, alongside a 44.0% gain over five years. Recent attention on Amphastar Pharmaceuticals has been shaped by ongoing discussions around its product portfolio and position...